Frederick Lam, Alvin Po-Ngai Chu, Fergus Kai-Chuen Wong, Jason Ying-Kuen Chan, Eddy Wai-Yeung Wong, Yuk-Fai Lau
{"title":"Clinical and Molecular Presentation of Respiratory Epithelial Adenomatoid Hamartoma: A Systematic Review.","authors":"Frederick Lam, Alvin Po-Ngai Chu, Fergus Kai-Chuen Wong, Jason Ying-Kuen Chan, Eddy Wai-Yeung Wong, Yuk-Fai Lau","doi":"10.1177/19458924261440421","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundRespiratory epithelial adenomatoid hamartoma (REAH) is a benign tumor-like lesion that appears in the sinonasal tract. Due to the lack of well-defined distinctive features of REAH, specifically clinical and molecular characteristics, this lesion is often misdiagnosed as an inflammatory nasal polyp or sinonasal malignancy.ObjectiveThis study aimed to systematically review the existing literature to determine the distinguishing attributes of REAH.MethodsIn accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a Medline, EMBASE and Web-of-Science literature review was undertaken to evaluate studies published till July 1, 2024. Forest and funnel plots were used to present prevalence and potential small-study effects, respectively. The estimates were calculated using random-effects methodology. The <i>I</i><sup>2</sup> value was determined to assess the interstudy heterogeneity. The quality of the included studies was evaluated using National Heart, Lung, and Blood Institute Study Quality Assessment Tools.ResultsA total of 39 studies were included, of which 10 investigated molecular characteristics. Several studies have shown the involvement of inflammatory processes in REAH. In addition, 37 studies with 1127 patients met the inclusion criteria for the meta-analysis. The findings of these studies showed that REAH was most commonly identified in the olfactory cleft (66.7% [49.8%-83.7%]), often bilaterally (66.4% [54.0%-78.7%]). Furthermore, REAH was associated with enlarged olfactory cleft widths on computed tomography scans, with an estimated width of 10.58 mm [9.41-11.75 mm].ConclusionOur study showed that inflammatory responses likely play a role in REAH. Notably, the symptoms of REAH are often indistinguishable from those of chronic rhinosinusitis with nasal polyposis. Thus, a high index of suspicion is required to diagnose REAH, typically when patients present with bilateral olfactory cleft masses with an enlarged olfactory cleft width on a computed tomography head scan.</p>","PeriodicalId":7650,"journal":{"name":"American Journal of Rhinology & Allergy","volume":" ","pages":"19458924261440421"},"PeriodicalIF":2.3000,"publicationDate":"2026-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Rhinology & Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/19458924261440421","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundRespiratory epithelial adenomatoid hamartoma (REAH) is a benign tumor-like lesion that appears in the sinonasal tract. Due to the lack of well-defined distinctive features of REAH, specifically clinical and molecular characteristics, this lesion is often misdiagnosed as an inflammatory nasal polyp or sinonasal malignancy.ObjectiveThis study aimed to systematically review the existing literature to determine the distinguishing attributes of REAH.MethodsIn accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a Medline, EMBASE and Web-of-Science literature review was undertaken to evaluate studies published till July 1, 2024. Forest and funnel plots were used to present prevalence and potential small-study effects, respectively. The estimates were calculated using random-effects methodology. The I2 value was determined to assess the interstudy heterogeneity. The quality of the included studies was evaluated using National Heart, Lung, and Blood Institute Study Quality Assessment Tools.ResultsA total of 39 studies were included, of which 10 investigated molecular characteristics. Several studies have shown the involvement of inflammatory processes in REAH. In addition, 37 studies with 1127 patients met the inclusion criteria for the meta-analysis. The findings of these studies showed that REAH was most commonly identified in the olfactory cleft (66.7% [49.8%-83.7%]), often bilaterally (66.4% [54.0%-78.7%]). Furthermore, REAH was associated with enlarged olfactory cleft widths on computed tomography scans, with an estimated width of 10.58 mm [9.41-11.75 mm].ConclusionOur study showed that inflammatory responses likely play a role in REAH. Notably, the symptoms of REAH are often indistinguishable from those of chronic rhinosinusitis with nasal polyposis. Thus, a high index of suspicion is required to diagnose REAH, typically when patients present with bilateral olfactory cleft masses with an enlarged olfactory cleft width on a computed tomography head scan.
呼吸道上皮性腺瘤样错构瘤(REAH)是一种出现在鼻窦的良性肿瘤样病变。由于REAH缺乏明确的特征,特别是临床和分子特征,这种病变经常被误诊为炎症性鼻息肉或鼻窦恶性肿瘤。目的对现有文献进行系统梳理,确定REAH的鉴别属性。方法根据系统评价和meta分析的首选报告项目指南,对截至2024年7月1日发表的研究进行Medline、EMBASE和Web-of-Science文献综述。森林图和漏斗图分别显示了患病率和潜在的小研究效应。估计值采用随机效应方法计算。测定I2值以评估研究间异质性。纳入研究的质量使用国家心脏、肺和血液研究所研究质量评估工具进行评估。结果共纳入39篇研究,其中10篇研究分子特性。一些研究表明炎症过程参与REAH。此外,37项研究1127例患者符合meta分析的纳入标准。这些研究结果表明,REAH最常见于嗅裂(66.7%[49.8%-83.7%]),常见于双侧(66.4%[54.0%-78.7%])。此外,REAH与计算机断层扫描的嗅裂宽度增大有关,估计宽度为10.58 mm [9.41-11.75 mm]。结论我们的研究表明炎症反应可能在REAH中起作用。值得注意的是,REAH的症状通常与慢性鼻窦炎伴鼻息肉病难以区分。因此,诊断REAH需要高度的怀疑指数,特别是当患者在计算机断层头部扫描中出现双侧嗅裂肿块并增大嗅裂宽度时。
期刊介绍:
The American Journal of Rhinology & Allergy is a peer-reviewed, scientific publication committed to expanding knowledge and publishing the best clinical and basic research within the fields of Rhinology & Allergy. Its focus is to publish information which contributes to improved quality of care for patients with nasal and sinus disorders. Its primary readership consists of otolaryngologists, allergists, and plastic surgeons. Published material includes peer-reviewed original research, clinical trials, and review articles.